307 participants
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-05-29
- Start Date:
- 2022-10-28
- Completion:
- 2025-05-28
Conditions
- Multiple Sclerosis
Interventions
- OTHER
No Results Yet